Foster Dykema Cabot & Partners’s Labcorp LH Stock Holding History

Foster Dykema Cabot & Partners’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$33.9K	Hold	127	–	–	﹤0.01%	200
2025 Q4	$31.9K	Hold	127	–	–	﹤0.01%	219
2025 Q3	$36.5K	Hold	127	–	–	﹤0.01%	237
2025 Q2	$33.3K	Hold	127	–	–	﹤0.01%	222
2025 Q1	$29.6K	Hold	127	–	–	﹤0.01%	221
2024 Q4	$29.1K	Hold	127	–	–	﹤0.01%	237
2024 Q3	$28.4K	Hold	127	–	–	﹤0.01%	277
2024 Q2	$25.8K	Hold	127	–	–	﹤0.01%	212
2024 Q1	$27.7K	Hold	127	–	–	﹤0.01%	212
2023 Q4	$28.9K	Buy	+127	New	+$26.7K	﹤0.01%	176

Other funds holding LH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Foster Dykema Cabot & Partners's LH Position: Q1 2026 in Review

Foster Dykema Cabot & Partners held its Labcorp (LH) position steady in Q1 2026 at 127 shares worth $33.9K. The position accounts for ﹤0.01% of the portfolio, ranked #200.

Foster Dykema Cabot & Partners first reported a position in LH in Q4 2023 and has held it in 10 quarters since. The position peaked at $36.5K in Q3 2025. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

Foster Dykema Cabot & Partners held 127 shares of Labcorp worth $33.9K as of Q1 2026.
Foster Dykema Cabot & Partners left its Labcorp share count unchanged in Q1 2026.
Labcorp made up ﹤0.01% of Foster Dykema Cabot & Partners's portfolio in Q1 2026, its #200 holding.
Foster Dykema Cabot & Partners first reported a position in Labcorp in Q4 2023 and has held it in 10 quarters since.
Foster Dykema Cabot & Partners's Labcorp position peaked at $36.5K in Q3 2025.
1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Foster Dykema Cabot & Partners's 13F filing for Q1 2026, filed 14 May 2026.